Peer Review History: Role of Tocilizumab in Combating Cytokine Storm in Moderate & Severe Covid 19 Patients: Retrospective Observational Study

Editor(s):

(1) Dr. Rafik Karaman, Professor, College of Pharmacy, Al-Quds University, Palestine.

(2) Dr. Sung-Kun Kim, Northeastern State University, USA.

Reviewers:

(1) Basser Ali Abdullah, University of Mosul, College of Dentistry, Iraq.

(2) Magesh Sachidanandam, King Institute of Preventive Medicine and Research, India.

(3) Zagrai Gavrila, University of Agricultural Sciences and Veterinary Medicine of Cluj-Napoca, Romania.

(4) Shoaeb Mohammad Syed, Dr. Vedprakash Patil Pharmacy College, India.

(5) Nestor Cahui Galarza, Universidad Nacional del Altiplano, PerĂº.

Additional Reviewers:

(1) M. Alagarraja, Dr.M.G.R. Medical University, India.

(2) Salim Hussein Hassan, Al Furat Al Awsat Technical University, Iraq.

(3) Mangirish N Deshpande, PES Rajaram and Tarabai Bandekar College of Pharmacy, India.

(4) Phillip M. Randall, Capella University, USA.

Open Peer Review Policy: Click Here

Specific Comment:

Average Peer review marks at initial stage: 8.38/10

Average Peer review marks at publication stage: 9/10

Peer Review History:


Stage 1 | Original Manuscript | File 1 | NA


Stage 2 | Peer review report_1 (Basser Ali Abdullah, Iraq) | File 1 | File 2


Stage 2 | Peer review report_2 (Magesh Sachidanandam, India) | File 1 | NA


Stage 2 | Peer review report_3 (Zagrai Gavrila, Romania) | File 1 | NA


Stage 2 | Peer review report_4 (Shoaeb Mohammad Syed, India) | File 1 | File 2


Stage 2 | Peer review report_5 (Nestor Cahui Galarza, PerĂº) | File 1 | File 2


Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2


Stage 3 | Comment_Editor_1_v1 | File 1 | NA


Stage 3 | Comment_Editor_2_v1 | File 1 | NA


Posted in Review History.